JP2023506030A5 - - Google Patents

Info

Publication number
JP2023506030A5
JP2023506030A5 JP2022535865A JP2022535865A JP2023506030A5 JP 2023506030 A5 JP2023506030 A5 JP 2023506030A5 JP 2022535865 A JP2022535865 A JP 2022535865A JP 2022535865 A JP2022535865 A JP 2022535865A JP 2023506030 A5 JP2023506030 A5 JP 2023506030A5
Authority
JP
Japan
Prior art keywords
seq
item
sarcoglycan
nos
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022535865A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023506030A (ja
JP7847084B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/065157 external-priority patent/WO2021126880A1/en
Publication of JP2023506030A publication Critical patent/JP2023506030A/ja
Publication of JP2023506030A5 publication Critical patent/JP2023506030A5/ja
Priority to JP2025087309A priority Critical patent/JP2025139591A/ja
Application granted granted Critical
Publication of JP7847084B2 publication Critical patent/JP7847084B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022535865A 2019-12-16 2020-12-15 ジストロフィン関連タンパク質複合体(dapc)を回復および維持するための組成物および方法 Active JP7847084B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025087309A JP2025139591A (ja) 2019-12-16 2025-05-26 ジストロフィン関連タンパク質複合体(dapc)を回復および維持するための組成物および方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962948586P 2019-12-16 2019-12-16
US62/948,586 2019-12-16
US202063023144P 2020-05-11 2020-05-11
US63/023,144 2020-05-11
PCT/US2020/065157 WO2021126880A1 (en) 2019-12-16 2020-12-15 Compositions and methods for restoring and maintaining the dystrophin-associated protein complex (dapc)

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025087309A Division JP2025139591A (ja) 2019-12-16 2025-05-26 ジストロフィン関連タンパク質複合体(dapc)を回復および維持するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2023506030A JP2023506030A (ja) 2023-02-14
JP2023506030A5 true JP2023506030A5 (cg-RX-API-DMAC7.html) 2023-12-22
JP7847084B2 JP7847084B2 (ja) 2026-04-16

Family

ID=76478281

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022535865A Active JP7847084B2 (ja) 2019-12-16 2020-12-15 ジストロフィン関連タンパク質複合体(dapc)を回復および維持するための組成物および方法
JP2025087309A Pending JP2025139591A (ja) 2019-12-16 2025-05-26 ジストロフィン関連タンパク質複合体(dapc)を回復および維持するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025087309A Pending JP2025139591A (ja) 2019-12-16 2025-05-26 ジストロフィン関連タンパク質複合体(dapc)を回復および維持するための組成物および方法

Country Status (4)

Country Link
US (1) US20230040544A1 (cg-RX-API-DMAC7.html)
EP (1) EP4117783A4 (cg-RX-API-DMAC7.html)
JP (2) JP7847084B2 (cg-RX-API-DMAC7.html)
WO (1) WO2021126880A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108463211B (zh) 2015-11-16 2022-09-27 全国儿童医院研究所 用于治疗肌联蛋白类肌病和其它肌联蛋白病变的材料和方法
TWI887479B (zh) * 2020-09-08 2025-06-21 美商薩羅塔治療公司 表現γ-肌聚醣之腺相關病毒載體之全身性遞送及肌肉失養症之治療
WO2023015304A1 (en) * 2021-08-05 2023-02-09 Insmed Incorporated Adeno-associated virus particles and methods of use thereof
US20230279431A1 (en) * 2021-11-30 2023-09-07 Research Institute At Nationwide Children's Hospital Self-Complementary Adeno-Associated Virus Vector and its Use in Treatment of Muscular Dystrophy
EP4198047A1 (en) * 2021-12-16 2023-06-21 Genethon Fukutin related protein gene transfer increase using modified itr sequences
EP4198048A1 (en) 2021-12-16 2023-06-21 Genethon Calpain-3 gene transfer increase using modified itr sequences
EP4198046A1 (en) * 2021-12-16 2023-06-21 Genethon Alpha-sarcoglycan gene transfer increase using modified itr sequences
IL317740A (en) * 2022-06-30 2025-02-01 Sarepta Therapeutics Inc Methods for treating muscular dystrophy
EP4551596A4 (en) * 2022-07-06 2026-07-22 Adverum Biotechnologies Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACHROMOTOPSY
AR133921A1 (es) 2023-09-25 2025-11-12 Sarepta Therapeutics Inc Distrofinas humanas adaptadas con mayor afinidad de unión a la actina para el tratamiento de las distrofias musculares
WO2025226842A1 (en) 2024-04-24 2025-10-30 Kate Therapeutics, Inc. Expression control by drg-expressed mirnas
WO2026011009A1 (en) 2024-07-02 2026-01-08 Kate Therapeutics, Inc. Compositions and methods for muscle disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043360A1 (en) * 1998-02-26 1999-09-02 The Trustees Of The University Of Pennsylvania Stable protection from dystrophic sarcolemmal degeneration and restoration of the sarcoglycan complex
US6262035B1 (en) * 1998-10-01 2001-07-17 University Of Iowa Research Foundation Gene replacement therapy for muscular dystrophy
US9434928B2 (en) * 2011-11-23 2016-09-06 Nationwide Children's Hospital, Inc. Recombinant adeno-associated virus delivery of alpha-sarcoglycan polynucleotides
WO2017165859A1 (en) * 2016-03-24 2017-09-28 Research Institute At Nationwide Children's Hospital Modified viral capsid proteins
CN109121395B (zh) * 2016-04-15 2022-08-09 全国儿童医院研究所 腺相关病毒载体递送β-肌聚糖和微RNA-29以及肌营养不良症的治疗
CN110997923B (zh) * 2017-03-17 2024-01-02 全国儿童医院研究所 腺相关病毒载体递送肌肉特异性微肌营养不良蛋白以治疗肌营养不良症
AU2019216257B2 (en) * 2018-01-31 2025-11-20 Research Institute At Nationwide Children's Hospital Gene therapy for limb-girdle muscular dystrophy type 2C

Similar Documents

Publication Publication Date Title
US20220331409A1 (en) Factor ix gene therapy
Daya et al. Gene therapy using adeno-associated virus vectors
TWI878204B (zh) 腺相關病毒載體遞送肌肉特異性微小肌縮蛋白以治療肌肉萎縮症
JP2025162557A5 (cg-RX-API-DMAC7.html)
JP2021106619A5 (cg-RX-API-DMAC7.html)
JP2021087431A5 (cg-RX-API-DMAC7.html)
JP2026027271A5 (cg-RX-API-DMAC7.html)
JP2020533959A5 (cg-RX-API-DMAC7.html)
CN114981444B (zh) Aav5的分离的修饰的vp1衣壳蛋白
JP2020522269A5 (cg-RX-API-DMAC7.html)
JP2022500066A5 (cg-RX-API-DMAC7.html)
JP2021512072A5 (cg-RX-API-DMAC7.html)
AU2019270972A1 (en) Stable expression of AAV vectors in juvenile subjects
JP2020513811A5 (cg-RX-API-DMAC7.html)
JP2019513393A5 (cg-RX-API-DMAC7.html)
JP2022547197A5 (cg-RX-API-DMAC7.html)
JP7558535B2 (ja) アルデヒドデヒドロゲナーゼ欠損症の治療のための遺伝子治療
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2023553005A5 (cg-RX-API-DMAC7.html)
JP2022525302A5 (cg-RX-API-DMAC7.html)
JP2023524414A5 (cg-RX-API-DMAC7.html)
JP2021534755A5 (cg-RX-API-DMAC7.html)
JP2024543001A5 (cg-RX-API-DMAC7.html)
JP2021534794A5 (cg-RX-API-DMAC7.html)
MX2023009978A (es) Composicion y metodos para el tratamiento de la enfermedad de fabry.